Bio-tech Facilities

Beacon Pharmaceuticals Ltd.’s manufacturing capabilities are aligned to a business strategy of developing and commercializing highest quality products across the globe. Beacon has extensive capabilities to develop and manufacture Recombinant proteins, monoclonal antibodies, pegylated technology platform products and plasma derived products.

Beacon is also the pioneer in introducing Liquid in Hard Gelatin Capsule technology which is safer than soft gel capsule.

The company’s capabilities encompass small-scale to large-scale pegylation, lyophilization, aseptic formulation and fill-finish. With complete aseptic integration, the facility carries-out fill-finish activity for pre-filled syringes, vials and pen-fill for devices.

• Multiple Class 10,000 stainless steel bioreactor suites for mammalian cell cultures
• Class 10,000 complete disposable bioreactor suite for mammalian cell cultures
• Multiple Class 10,000 purification suites for downstream processing
• Class 100 suite each for filling into pre-filled syringes, vials and cartridges
• Class 10,000 suite for pegylated products manufacturing
• In-house facilities for visual inspection of finished goods, packaging, and dispatch